182 related articles for article (PubMed ID: 24510488)
21. Antibody engineering, a strategy for the development of monoclonal antibodies.
Schönherr OT; Houwink EH
Antonie Van Leeuwenhoek; 1984; 50(5-6):597-623. PubMed ID: 6099095
[TBL] [Abstract][Full Text] [Related]
22. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
23. Culturing hybridoma cell lines for monoclonal antibody production.
Winzeler A; Wang JT
Cold Spring Harb Protoc; 2013 Jul; 2013(7):640-2. PubMed ID: 23818668
[TBL] [Abstract][Full Text] [Related]
24. [Monoclonal antibodies produced by human-human hybridomas].
Chida J
Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
[TBL] [Abstract][Full Text] [Related]
25. [Current developments in hybridoma technology].
Osterhaus AD; UytdeHaag AG
Tijdschr Diergeneeskd; 1985 Oct; 110(20):835-9. PubMed ID: 3878011
[TBL] [Abstract][Full Text] [Related]
26. Alloimmunization with cultured human stomach cancer cell lines and the establishment of human-human hybridomas producing monoclonal antibodies.
Koyama K; Akiyama K; Kawahara H; Egashira A; Murakami H
Jpn J Cancer Res; 1990 Oct; 81(10):967-70. PubMed ID: 2121682
[TBL] [Abstract][Full Text] [Related]
27. High frequency production of hybridomas secreting antibodies to cell antigens.
Cianfriglia M; Nuti M; Turchi V; Barca S; Tombesi M; Morrone S; Cenciarelli C; Natali PG
Hybridoma; 1987 Dec; 6(6):673-7. PubMed ID: 3501765
[TBL] [Abstract][Full Text] [Related]
28. Production of monoclonal antibody supernatant and ascites fluid.
Yokoyama WM
Curr Protoc Mol Biol; 2001 May; Chapter 11():Unit11.10. PubMed ID: 18265068
[TBL] [Abstract][Full Text] [Related]
29. A practical method for rescuing desired hybridomas during monoclonal antibody production.
Adamus G; Zam ZS; Emerson SS; Hargrave PA
In Vitro Cell Dev Biol; 1989 Dec; 25(12):1141-6. PubMed ID: 2691498
[TBL] [Abstract][Full Text] [Related]
30. Collecting and Storing Hybridoma Tissue Culture Supernatants.
Greenfield EA
Cold Spring Harb Protoc; 2020 Oct; 2020(10):. PubMed ID: 33004553
[TBL] [Abstract][Full Text] [Related]
31. Increasing hybridoma viability and antibody repertoire after the cell fusion by the use of human plasma as an alternative supplement.
Lee RJ; Wu JS; Juang RH; Wu YJ; Lin CY; Wu SY; Huang PR; Chu CH; Chin LT; Chen HM
J Immunol Methods; 2010 Sep; 361(1-2):89-97. PubMed ID: 20723546
[TBL] [Abstract][Full Text] [Related]
32. Efficient generation of stable antibody forming hybridoma cells by electrofusion.
Schmitt JJ; Zimmermann U; Neil GA
Hybridoma; 1989 Feb; 8(1):107-15. PubMed ID: 2925206
[TBL] [Abstract][Full Text] [Related]
33. The EBV-hybridoma technique.
Roder JC; Cole SP; Kozbor D
Methods Enzymol; 1986; 121():140-67. PubMed ID: 3014265
[No Abstract] [Full Text] [Related]
34. Tetramer Immunization and Selection Followed by CELLISA Screening to Generate Monoclonal Antibodies against the Mouse Cytomegalovirus m12 Immunoevasin.
Aguilar OA; Tanaka M; Balaji GR; Berry R; Rossjohn J; Lanier LL; Carlyle JR
J Immunol; 2020 Sep; 205(6):1709-1717. PubMed ID: 32817368
[TBL] [Abstract][Full Text] [Related]
35. Cell hybridization, hybridomas, and human hybridomas.
Shirahata S; Katakura Y; Teruya K
Methods Cell Biol; 1998; 57():111-45. PubMed ID: 9648102
[TBL] [Abstract][Full Text] [Related]
36. [A strategy for the production of human monoclonal antibodies].
Chiba J
Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies against a plant virus.
Dietzgen RG; Sander E
Arch Virol; 1982; 74(2-3):197-204. PubMed ID: 6187313
[TBL] [Abstract][Full Text] [Related]
38. Study on rat-rat hybridoma technique and production of rat monoclonal antibodies against HIV and HBsAg.
Fang JC; Bodeus M; Burtonboy G
Chin J Biotechnol; 1991; 7(1):73-81. PubMed ID: 1773018
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies: methods and clinical laboratory applications.
Nakamura RM
Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of limiting dilution in cloning mouse myeloma-spleen hybridomas by human low density lipoproteins.
Mao SJ; France DS
J Immunol Methods; 1984 Dec; 75(2):309-16. PubMed ID: 6520402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
